Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evening versus Morning Levothyroxine Administration
NL-OMON26022Phase 4Not yet recruiting
- Sponsor
- Maasstad Ziekenhuis
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of levothyroxine sodium in primary hypothyroidism (PH) and hypothyroidism (2 arms), sponsored by Maasstad Ziekenhuis. Primary endpoints: Change in TSH, Change in free T4 and 1 more. Planned start Jan 2007; status: not yet recruiting.
02
Drugs
levothyroxine sodium
03
Conditions
primary hypothyroidism (PH)hypothyroidism
Beyond the preview
Go deeper on NL-OMON26022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26022.